Ertapenem Injection, Powder, Lyophilized, For Solution
Product Images NDC 68083-351

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ertapenem (NDC 68083-351). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ertapenem Spl Carton Label

Packaging label for Ertapenem for Injection 1g/Vial, a lyophilized powder for solution intended for intravenous or intramuscular use. The label indicates a package of 10 single dose vials with NDC 68083-351-10. Manufactured by Gland Pharma Limited, Hyderabad, India, the label includes storage instructions and a barcode.*

FDA Label Image

Ertapenem Spl Container Label

Label for Ertapenem for Injection 1g/Vial, a lyophilized powder for solution intended for intravenous or intramuscular use. The label states it contains 1.046 grams ertapenem sodium equivalent to 1 gram ertapenem, along with inactive ingredients for pH adjustment. It is manufactured by Gland Pharma Limited, Hyderabad, India, and includes space for batch and expiry date information.*

FDA Label Image

Ertapenem Spl Structure

Chemical structure diagram of ertapenem sodium, showing its molecular framework including beta-lactam and carboxylate groups along with sodium ion association.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.